Improving environmental risk assessments of chemicals: Steps towards evidence-based ecotoxicology

© 2019 The Authors. Highlights • 9 recommendations digest recent developments in regulatory environmental risk assessment. • Efforts are necessary to make the translation of ecotoxicology into regulatory decisions more open and transparent. • They require concerted and sustained action from a variety of sectors and stakeholders. • Better evidence will lead to better decisions, sustainable innovation and a healthier environment

Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms

One of the most promising applications of synthetic biology is the biosynthesis of new drugs from secondary metabolites. Here, we survey a wide range of strategies that control the activity of biosynthetic modules in the cell in space and time, and illustrate how these strategies can be used to design efficient cellular synthetic production systems. Re-engineered versions of secondary metabolite biosynthetic pathways identified from any genomic sequence can then be inserted into these systems in a plug-and-play fashion

A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke

We expanded our genome-wide association study on atrial fibrillation (AF) in Iceland, which previously identified risk variants on 4q25, and tested the most significant associations in samples from Iceland, Norway and the United States. A variant in the ZFHX3 gene on chromosome 16q22, rs7193343-T, associated significantly with AF (odds ratio OR = 1.21, P = 1.4 x 10(-10)). This variant also associated with ischemic stroke (OR = 1.11, P = 0.00054) and cardioembolic stroke (OR = 1.22, P = 0.00021) in a combined analysis of five stroke samples